
SpliSense
Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.
About
SpliSense is a biotechnology company developing transformative RNA-based treatments for pulmonary diseases. Their innovative therapies utilize Antisense Oligonucleotides (ASOs) to restore and modify protein functionality, targeting the root cause of conditions like Cystic Fibrosis and Muco-Obstructive Pulmonary Diseases.
Listed competitors
Also in this space
Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Shares Healthcare, Biotech
Develops a computational model of the human body for drug discovery and development.
Shares Healthcare, Drug Discovery
AI-powered spatial biology platform for precision medicine and drug development.
Shares Healthcare, HealthTech
AI-powered platform for profiling cancer biomarkers from digitized biopsy images.
Shares Healthcare, Genomics
Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.
Shares Healthcare, Genomics
Data-driven drug discovery and development company using machine learning and high-throughput biology.
Shares Healthcare, Drug Discovery
Key facts
- Website
- splisense.com
- Headquarters
- Rehovot, Israel
- Founded
- 2017
- Employees
- 16
- Total funding
- $29M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 13 May 2021 | Series B | $29M |
Tech stack
Detected on splisense.com, last scanned 30 Oct 2026. Run your own scan
- Frontend
- jQuery
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
SpliSense scores 11. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is SpliSense trustworthy and reputable?
StartupHub's Data Trust & Reputation score for SpliSense is 78 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has SpliSense raised?
SpliSense has raised a total of $29M in funding. The most recent round on record is Series B.
How many employees does SpliSense have?
SpliSense has approximately 16 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for SpliSense

